Search research articles
Contact Us
Filters
Showing results (191-200 of 248) with videos related to
Page
of 25
Sort By:
Nucleic Acids Research
|
December 22, 2022
SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression
Laura Cioetto-Mazzabò, Francesca Boldrin, Claire Beauvineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
BMJ Open
|
November 17, 2025
Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol
Sam Wilding, Victoria Goss, Wesley Sukdao, et al.
BMJ Open
|
August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz, Fay Chinnery, Beth Stuart, et al.
British Journal of Cancer
|
January 11, 2017
Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial
Richard D Neal, Allan Barham, Emily Bongard, et al.
BMJ Open
|
November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres
Dean Fennell, Daniel Griffiths, Zina Eminton, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, et al.
BMC Complementary Medicine and Therapies
|
January 30, 2021
Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial
Merlin Willcox, Catherine Simpson, Sam Wilding, et al.
AAPS Pharmscitech
|
June 8, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis
Sonia Verma, Nils-Jorgen K Dal, Ashish Srivastava, et al.
BMJ Open
|
December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
Sarah Pyne, Tracey H Sach, Megan Lawrence, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 248) with videos related to
Sort By:
Page
of 25
Nucleic Acids Research
|
December 22, 2022
SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression
Laura Cioetto-Mazzabò, Francesca Boldrin, Claire Beauvineau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Somnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
BMJ Open
|
November 17, 2025
Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol
Sam Wilding, Victoria Goss, Wesley Sukdao, et al.
BMJ Open
|
August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz, Fay Chinnery, Beth Stuart, et al.
British Journal of Cancer
|
January 11, 2017
Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial
Richard D Neal, Allan Barham, Emily Bongard, et al.
BMJ Open
|
November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres
Dean Fennell, Daniel Griffiths, Zina Eminton, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2023
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial
Miriam Santer, Megan Lawrence, Susanne Renz, et al.
BMC Complementary Medicine and Therapies
|
January 30, 2021
Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial
Merlin Willcox, Catherine Simpson, Sam Wilding, et al.
AAPS Pharmscitech
|
June 8, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis
Sonia Verma, Nils-Jorgen K Dal, Ashish Srivastava, et al.
BMJ Open
|
December 11, 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
Sarah Pyne, Tracey H Sach, Megan Lawrence, et al.
Page
of 25